Detalhe da pesquisa
1.
Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.
Cell;
172(1-2): 191-204.e10, 2018 01 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29224778
2.
Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia.
Cell;
167(1): 171-186.e15, 2016 Sep 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27641501
3.
Not All Created Equal: Lineage Hard-Wiring in the Production of Blood.
Cell;
163(7): 1568-70, 2015 Dec 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26687347
4.
Xist RNA is a potent suppressor of hematologic cancer in mice.
Cell;
152(4): 727-42, 2013 Feb 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23415223
5.
Proton export alkalinizes intracellular pH and reprograms carbon metabolism to drive normal and malignant cell growth.
Blood;
139(4): 502-522, 2022 01 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34610101
6.
CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia.
Ann Hematol;
2023 Sep 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37736806
7.
Metabolomic Study Using Time-of-Flight Mass Spectrometry Reveals Novel Urinary Biomarkers for Gaucher Disease Type 1.
J Proteome Res;
21(5): 1321-1329, 2022 05 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35349295
8.
Identification of a Reliable Biomarker Profile for the Diagnosis of Gaucher Disease Type 1 Patients Using a Mass Spectrometry-Based Metabolomic Approach.
Int J Mol Sci;
21(21)2020 Oct 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33114153
9.
ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells.
Blood;
130(5): 619-624, 2017 08 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28615219
10.
Nucleic acid therapeutics as differentiation agents for myeloid leukemias.
Leukemia;
2024 Feb 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38424137
11.
Leukemia aggressiveness is driven by chromatin remodeling and expression changes of core regulators.
bioRxiv;
2024 Mar 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38496490
12.
Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells.
Exp Hematol;
121: 6-11, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36764598
13.
PARP-1 improves leukemia outcomes by inducing parthanatos during chemotherapy.
Cell Rep Med;
4(9): 101191, 2023 09 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37683650
14.
CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
Cell Rep;
42(9): 113084, 2023 09 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37716355
15.
Quantitation of a Urinary Profile of Biomarkers in Gaucher Disease Type 1 Patients Using Tandem Mass Spectrometry.
Diagnostics (Basel);
12(6)2022 Jun 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35741225
16.
Recent Advances in Cancer Drug Discovery Through the Use of Phenotypic Reporter Systems, Connectivity Mapping, and Pooled CRISPR Screening.
Front Pharmacol;
13: 852143, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35795568
17.
Quantitation of a plasma biomarker profile for the early detection of Gaucher disease type 1 patients.
Bioanalysis;
14(4): 223-240, 2022 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35118875
18.
m6A RNA modifications: Key regulators of normal and malignant hematopoiesis.
Exp Hematol;
111: 25-31, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35487293
19.
EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax.
J Exp Clin Cancer Res;
41(1): 340, 2022 Dec 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36482393
20.
Lysosphingolipid urine screening test using mass spectrometry for the early detection of lysosomal storage disorders.
Bioanalysis;
14(5): 289-306, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35118880